FRI0584 EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE
Published: Jun 1, 2019
Abstract
Background
IgG4-related disease(IgG4-RD) is a systemic fibro-inflammatory disease. Treatment is based on corticosteroids(CS) but up to 50% of patients may relapse. Rituximab(RTX) has emerged as an effective treatment option[1].Objectives
To assess the free relapse rate(FRR) in patients receiving or not maintenance RTX therapy. Secondary outcomes: time to relapse, incidence of adverse events and differences in FRR between Group...Paper Details
Title
FRI0584 EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE
Published Date
Jun 1, 2019
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History